Unknown

Dataset Information

0

Clinical Implications of (Pro)renin Receptor (PRR) Expression in Renal Tumours.


ABSTRACT: (1) Background: Renal cancer is one of the most frequent malignancies in Western countries, with an unpredictable clinical outcome, partly due to its high heterogeneity and the scarcity of reliable biomarkers of tumour progression. (Pro)renin receptor (PRR) is a novel receptor of the renin-angiotensin system (RAS) that has been associated with the development and progression of some solid tumours by RAS-dependent and -independent mechanisms. (2) Methods: In this study, we analysed the immunohistochemical expression of PRR at the centre and border in a series of 83 clear-cell renal cell (CCRCCs), 19 papillary (PRCC) and 7 chromophobe (ChRCC) renal cell carcinomas, and the benign tumour renal oncocytoma (RO, n = 11). (3) Results: PRR is expressed in all the tumour subtypes, with higher mean staining intensity in ChRCCs and ROs. A high expression of PRR at the tumour centre and at the infiltrative front of CCRCC tissues is significantly associated with high grade, tumour diameter, local invasion and stage, and with high mortality risk by UCLA integrated staging system (UISS) scale. (4) Conclusions: These findings indicate that PRR is associated with the development and progression of renal tumours. Its potential as a novel biomarker for RCC diagnosis/prognosis and as a promising therapeutic target should be taken into account in the future.

SUBMITTER: Solano-Iturri JD 

PROVIDER: S-EPMC7916453 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Clinical Implications of (Pro)renin Receptor (PRR) Expression in Renal Tumours.

Solano-Iturri Jon Danel JD   Echevarría Enrique E   Unda Miguel M   Loizaga-Iriarte Ana A   Pérez-Fernández Amparo A   Angulo Javier C JC   López José I JI   Larrinaga Gorka G  

Diagnostics (Basel, Switzerland) 20210210 2


(1) Background: Renal cancer is one of the most frequent malignancies in Western countries, with an unpredictable clinical outcome, partly due to its high heterogeneity and the scarcity of reliable biomarkers of tumour progression. (Pro)renin receptor (PRR) is a novel receptor of the renin-angiotensin system (RAS) that has been associated with the development and progression of some solid tumours by RAS-dependent and -independent mechanisms. (2) Methods: In this study, we analysed the immunohist  ...[more]

Similar Datasets

| S-EPMC4881895 | biostudies-literature
| S-EPMC4200301 | biostudies-literature
| S-EPMC8191636 | biostudies-literature
| S-EPMC5814590 | biostudies-literature
| S-EPMC3266459 | biostudies-literature
| S-EPMC5556690 | biostudies-literature
| S-EPMC8080643 | biostudies-literature
| S-EPMC6690878 | biostudies-literature
| S-EPMC6462324 | biostudies-literature
| S-EPMC3822843 | biostudies-other